Zobrazeno 1 - 10
of 30
pro vyhledávání: '"59"'
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:1253-1261
Purpose Growing numbers of clinical trials test the efficacy of radiotherapy (RT) plus immune checkpoint inhibitors (ICIs), but the number of irradiated sites is not uniform. We aimed to evaluate the efficacy of single-site RT plus immunotherapy in o
Autor:
Xiaobin Zheng, Zhinan Xie, Cuiling Zhou, Haiqing Ma, Huanhuan Sun, Junlan Qiu, Xiaofeng Pei, Gang Che, Hongyu Zhang, Yunyan Cong
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 145:2663-2674
It is known that there are insufficient prognostic factors for non-small cell lung cancer (NSCLC). It was reported that PD-L1 was a prognostic factor for NSCLC,and c-Myc regulated the expression of PD-L1. Herein, we investigated c-Myc and PD-L1 expre
Autor:
Na Li, Dong Wang, Tianyou Wang, Hongyun Lian, Liping Zhang, Yunze Zhao, Wei Liu, Zhigang Li, Rui Zhang, Honghao Ma, Wanshui Wu, Ying Yang, Lei Cui, Chanjuan Wang, Yizhuo Wang
Publikováno v:
Journal of cancer research and clinical oncology. 148(9)
Purpose To analyze the genetic and clinical features of children with MAP2K1-mutated Langerhans cell histiocytosis (LCH). Methods We compared the clinical features of 37 children with MAP2K1-mutated LCH with those of the BRAFV600E mutation group (n =
Autor:
Jan Stratmann, Michael Hogardt, Stefan Zeuzem, Mate Knabe, Phillip G. Ferstl, Olivier Ballo, Vera Himmelsbach, Kai-Henrik Peiffer, Volkhard A. J. Kempf, Thomas A. Wichelhaus, Oliver Waidmann, Fabian Finkelmeier
Publikováno v:
Journal of cancer research and clinical oncology. 148(6)
Introduction MDRO-colonization has been shown to impair survival in patients with hematological malignancies and solid tumors as well as in patients with liver disease. Despite the increasing spread of multidrug-resistant organisms (MDRO), its impact
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 145:1857-1864
To evaluate the value of concurrent chemotherapy after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma (NPC) in the era of intensity-modulated radiation therapy (IMRT), we performed this retrospective cohort study to compa
Autor:
Jai Young Cho, Kwhanmien Kim, Sukki Cho, Sang A. Kim, Duck Woo Kim, Ji Won Kim, Jee Hyun Kim, Heung Kwon Oh, Won Chang, Sanghoon Jheon, Koung Jin Suh, Sung Bum Kang, Jin Won Kim, Keun Wook Lee
Publikováno v:
Journal of cancer research and clinical oncology. 146(9)
Some metastatic colorectal cancer (mCRC) patients receive conversion surgery (CS), including metastasectomy after palliative chemotherapy. Although targeted agents significantly improved the outcomes, the clinical outcome of CS in the targeted agent
Autor:
Manuel Valladares-Ayerbes, Julien Taieb, Javier Gallego, Michael Geissler, Reija Koukakis, Fernando Rivera, Gaston Demonty, Meinolf Karthaus, Marc Peeters, Salvatore Siena
Publikováno v:
Journal of cancer research and clinical oncology
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology
Purpose To report exploratory analyses of early tumour shrinkage (ETS) and depth of response (DpR) in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC), receiving the first-line treatment in three randomised panitumumab trials. Met
Publikováno v:
Journal of cancer research and clinical oncology. 145(7)
To study integrin α6 expression in lung adenocarcinoma tissue through comparison with matching adjacent non-cancerous tissues as well as elucidating the correlation between integrin α6 expression with the clinical parameters of lung adenocarcinoma.
Autor:
Leonardo Giovannoni, Horst Dürkop, Ricarda Locher, Paola Anna Erba, Emilio Bombardieri, Hans D. Menssen, Burkhard Hirsch, Dario Neri
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 140:35-43
The extradomain B of fibronectin (ED-B) is a promising vascular target for selective pharmacodelivery in cancer patients. We analyzed a large series of prostatectomies from patients with prostate cancer, hyperplastic prostate disease, and normal pros
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 139:1523-1528
Fibroblast activation protein-α (FAP-α), which is a serine protease specially expressed on the surface of the cancer stromal cells, plays an important role in the progression and prognosis in diverse malignancies. However, the role of FAP-α in non